
In April 2026, the Parkinson’s Foundation hosted an expert briefing titled “Inside the Science: Parkinson’s Research Today.” Laurie Sanders, PhD, associate professor of neurology at Duke University, shared why she and many of her colleagues are increasingly optimistic about the direction of Parkinson’s disease research. Dr. Sanders focused on three key research areas — alpha-synuclein, mitochondrial function, and neuroinflammation — and explained how these pathways are now understood to be interconnected, opening new doors for disease-modifying therapies. This was a technical webinar. If this talk taught me anything, it’s that Parkinson’s disease is far more complex than most of us realize. I found myself looking up terms throughout — so consider this my best attempt at summarizing the science.
… Full Story>

